title: Any effect of CYP2C9 variants on warfarin clearance in Chinese patients?
authors.forename: Joyce H S
authors.initials: JH
authors.lastname: You
authors.forename: Zhong
authors.initials: Z
authors.lastname: Zuo
authors.forename: Cindy M Y
authors.initials: CM
authors.lastname: Lo
authors.forename: Limin
authors.initials: L
authors.lastname: Zhou
authors.forename: Hillary H W
authors.initials: HH
authors.lastname: Yiu
authors.forename: Carrie T S
authors.initials: CT
authors.lastname: Chau
authors.forename: Kai Chow
authors.initials: KC
authors.lastname: Choi
authors.forename: David K M
authors.initials: DK
authors.lastname: Choi
authors.forename: Raymond S M
authors.initials: RS
authors.lastname: Wong
authors.forename: Gregory
authors.initials: G
authors.lastname: Cheng
mesh_terms: D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000737:chemistry / Q000493:pharmacokinetics*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D044466:Asian People / Q000235:genetics; D015331:Cohort Studies; D065729:Cytochrome P-450 CYP2C9; D005260:Female; D014644:Genetic Variation; D006723:Hong Kong; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate / Q000235:genetics; D008875:Middle Aged; D013237:Stereoisomerism; D014859:Warfarin / Q000737:chemistry / Q000493:pharmacokinetics*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases